Literature DB >> 23046872

A cross-linked polymeric micellar delivery system for cisplatin(IV) complex.

Haiqin Song1, Rui Wang, Haihua Xiao, Haidong Cai, Wenjing Zhang, Zhigang Xie, Yubin Huang, Xiabin Jing, Tongjun Liu.   

Abstract

A polymeric cisplatin(IV) prodrug in the form of cross-linked micelles (M(Pt(IV)) was prepared by first constructing MPEG-b-PCL-b-PLL micelles and then attaching a cisplatin(IV) complex with two axial succinic moieties to the lysine residues of the carrier polymer in aqueous medium. The micelles obtained were characterized by TEM, DLS, and zeta potential measurement. Their in vitro release experiments were carried out at pH 7.4 and 5.0 or in the presence of 5mM sodium ascorbate (NaAsc). Results showed that the micelles were sensitive to both acidic hydrolysis and mild reducing agents; in the presence of 5mM NaAsc, cisplatin(II) was directly released and the released cisplatin(II) could chelate with nucleobases; the micelles displayed comparable cytotoxicities to cisplatin; and the micelles were much more efficiently internalized by the cells than cisplatin(II) and cisplatin(IV) counterparts. Moreover, in vivo study showed accumulation of more Pt species in the tumor site and lower systematic toxicity compared to free cisplatin(II) and cisplatin(IV). This polymeric prodrug of cisplatin is expected to be used more for future study and applications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046872     DOI: 10.1016/j.ejpb.2012.09.004

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

2.  A Theranostic Nanocomplex Combining with Magnetic Hyperthermia for Enhanced Accumulation and Efficacy of pH-Triggering Polymeric Cisplatin(IV) Prodrugs.

Authors:  Yang Qu; Zhiqi Wang; Miao Sun; Tian Zhao; Xuanlei Zhu; Xiaoli Deng; Man Zhang; Ying Xu; Hongfei Liu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-14

Review 3.  Nanoparticle formulations of cisplatin for cancer therapy.

Authors:  Xiaopin Duan; Chunbai He; Stephen J Kron; Wenbin Lin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-02-05

4.  Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.

Authors:  Yuan Hong; Shaomin Che; Beina Hui; Xiaoli Wang; Xiaozhi Zhang; Hailin Ma
Journal:  Drug Des Devel Ther       Date:  2020-06-09       Impact factor: 4.162

5.  Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.

Authors:  Feng Yang; Aimei Li; Han Liu; Hairong Zhang
Journal:  Drug Des Devel Ther       Date:  2018-10-04       Impact factor: 4.162

Review 6.  Polymeric Nanosystems Applied for Metal-Based Drugs and Photosensitizers Delivery: The State of the Art and Recent Advancements.

Authors:  Kele Cristina Ferreira Dantas; Jânia Dos Santos Rosário; Priscila Pereira Silva-Caldeira
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.